INS and diabetes mellitus: The recipient candidates also suffered from diabetes with insulin dependence that had persisted for more than 5 years, showed a severe decrease in endogenous insulin secretion (serum C-peptide < 0.2 ng/mL), and had significant difficulty in blood glucose control, even when the patient’s treatment was managed by a diabetes specialist.